Clinical Trials Directory

Trials / Unknown

UnknownNCT02544958

Er:YAG Laser for Treatment of Enlarged Pores

The Efficacy and Safety of Erbium:Yttrium Aluminum Garnet Laser for Treatment of Enlarged Pores: A Pilot Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
24 (estimated)
Sponsor
Mahidol University · Academic / Other
Sex
All
Age
25 Years – 60 Years
Healthy volunteers
Accepted

Summary

To investigate the efficacy of Erbium:Yttrium aluminum garnet laser (Er:YAG) in the treatment of enlarged pores.

Detailed description

* Enlarged pores are caused by multifactorial factors such as sex, genetics, aging, etc. * The gold of the treatment is to recollagenesis of the dermis and resurfacing of the epidermis. * Modalities that have been proved on their efficacy for enlarged pores treatment included topical retinoic acid, chemical peeling, intense pulsed light, radiofrequency device, laser such as Q-switched and Long Pulsed Neodymium-Doped Yttrium-Aluminum-Garnet (Nd:YAG) 1,064nm, Long pulse duration pulsed dye laser 595nm, etc. * Er:YAG laser is an ablative laser which creates both recollagenesis and resurfacing. It ha been proved to be safe and effective in the treatment of atrophic acne scar. * However, the efficacy of this laser for enlarged treatment has not yet been established.

Conditions

Interventions

TypeNameDescription
DEVICEEr:YAG laserEr:YAG laser treats enlarged pores on both sides of the face for 4 treatments of 1 month interval.

Timeline

Start date
2015-05-01
Primary completion
2016-07-01
Completion
2016-08-01
First posted
2015-09-09
Last updated
2016-06-01

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT02544958. Inclusion in this directory is not an endorsement.